Sign In
Buy AMRX
$12.88
+0.225 (+1.78%)
At Close: Jun 03, 2026
Huge boost for Covid-19 vaccine with test monkeys infection-free four weeks on
04:02am, Tuesday, 28'th Apr 2020
'Millions' of doses of Oxford University's vaccine could be available as early as September with human trials, consisting of 6,000 participants, set to begin in May, it has been reported
SVB Leerink Equities Analysts Increase Earnings Estimates for Amneal Pharmaceuticals Inc (NYSE:AMRX)
08:18am, Monday, 27'th Apr 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) – Stock analysts at SVB Leerink upped their FY2021 earnings per share (EPS) estimates for Amneal Pharmaceuticals in a research note issued on Thursday, April 2
Amneal to Report First Quarter 2020 Results on May 11, 2020
08:05pm, Friday, 24'th Apr 2020
Amneal to Report First Quarter 2020 Results on May 11, 2020
FACTBOX-Global pharma industry steps up efforts to battle coronavirus
04:42pm, Friday, 24'th Apr 2020
Drugmakers across the globe are rushing to develop a treatment or vaccine for the fast-spreading coronavirus that has wreaked havoc across the globe,
killing over 191,000 people and ravaging financial
FDA cautions on use of malaria drugs for COVID-19 outside of hospitals
02:15pm, Friday, 24'th Apr 2020
In a statement, the FDA is cautioning against the use of malaria meds chloroquine and hydroxychloroquine outside of the hospital setting for the treatment of COVID-19 due to the risk of adverse heart
Finnish drugmaker Orion raises profit view as coronavirus lifts demand
01:47pm, Friday, 24'th Apr 2020
Finnish drugmaker Orion raised its 2020 operating profit forecast on Friday, helped by strong demand for drugs including a sedative and a respiratory treatment due to coronavirus pandemic.
UPDATE 1-Finnish drugmaker Orion raises profit view as coronavirus lifts demand
01:45pm, Friday, 24'th Apr 2020
Finnish drugmaker Orion raised its 2020 operating profit forecast on Friday, helped by strong demand for drugs including a sedative and a respiratory treatment due to coronavirus pandemic.
Royal Bank of Canada Reiterates Hold Rating for Amneal Pharmaceuticals (NYSE:AMRX)
09:58am, Monday, 20'th Apr 2020
Royal Bank of Canada reaffirmed their hold rating on shares of Amneal Pharmaceuticals (NYSE:AMRX) in a research note released on Thursday morning, AnalystRatings.com reports. They currently have a $4.
Ladenburg Thalmann Financial Services Inc. Sells 7,373 Shares of Amneal Pharmaceuticals Inc (NYSE:AMRX)
10:58am, Sunday, 19'th Apr 2020
Ladenburg Thalmann Financial Services Inc. lowered its stake in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) by 17.0% during the fourth quarter, Holdings Channel.com reports. The firm owned 36,094
Cubist Systematic Strategies LLC Sells 40,394 Shares of Amneal Pharmaceuticals Inc (NYSE:AMRX)
08:16am, Sunday, 19'th Apr 2020
Cubist Systematic Strategies LLC lessened its holdings in shares of Amneal Pharmaceuticals Inc (NYSE:AMRX) by 62.7% during the 4th quarter, according to the company in its most recent disclosure with
Amneal Pharmaceuticals Inc (NYSE:AMRX) Shares Bought by Alliancebernstein L.P.
09:20am, Saturday, 18'th Apr 2020
Alliancebernstein L.P. raised its holdings in Amneal Pharmaceuticals Inc (NYSE:AMRX) by 3.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 233,249 shares of
Research Analysts Issue Forecasts for Amneal Pharmaceuticals Inc's FY2020 Earnings (NYSE:AMRX)
07:44am, Saturday, 18'th Apr 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) – Equities research analysts at Piper Sandler cut their FY2020 earnings per share (EPS) estimates for Amneal Pharmaceuticals in a research report issued to cli
Q1 2020 EPS Estimates for Amneal Pharmaceuticals Inc Decreased by Piper Sandler (NYSE:AMRX)
06:28am, Saturday, 18'th Apr 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) – Piper Sandler dropped their Q1 2020 earnings per share (EPS) estimates for Amneal Pharmaceuticals in a note issued to investors on Tuesday, April 14th. Piper
Amneal Pharmaceuticals Inc (NYSE:AMRX) Short Interest Up 17.6% in March
09:02am, Friday, 17'th Apr 2020
Amneal Pharmaceuticals Inc (NYSE:AMRX) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 6,230,000 shares, an incr
RBC Capital Maintains a Hold Rating on Amneal Pharmaceuticals (AMRX)
05:52pm, Thursday, 16'th Apr 2020
In a report released yesterday,
Randall Stanicky
from RBC Capital maintained a
Hold
rating on Amneal Pharmaceuticals (
AMRX
–
Research Report
), with a price target of
$4.00
. The company’s shares
